Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alkaline extract of pine seed shell (APs) is a botanical extract derived from the woody outer layer of pine seeds through alkaline processing. This extraction method yields a substance rich in lignin degradation products, which are known for their diverse biological activities. Research indicates that APs possesses significant anti-ultraviolet C (UVC) activity, suggesting potential applications in photoprotection and the prevention of radiation-induced cellular damage. Furthermore, APs has been shown to stimulate macrophage activation, enhancing phagocytic activity and potentially modulating the immune response. These properties position APs as a candidate for development in the fields of nutraceuticals, dermatology, and immunomodulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alkaline extract of pine seed shell.